Honeywell is a fascinating company to trade around earnings precisely because the market consistently prices it as if perfection is the baseline. Q1 2026 delivered an EPS beat — $2.45 against $2.32 consensus — and the stock initially responded positively. By April 25, it was trading at $212, down from the $217 it was printing before the details came out. The beat didn't save it.
What I Saw
I've watched Honeywell earnings setups long enough to recognize the pattern: any revenue miss or soft guidance tends to overwhelm the EPS number in the market's reaction, particularly when the stock carries a premium multiple heading into the print.
Q1 revenue of $9.14 billion came in below the $9.30 billion estimate. And Q2 guidance landed below consensus — a combination that's almost algorithmically negative for a stock like HON. Citi cut their price target shortly after. The initial pop faded by midday.
The Trade
After the initial reaction on April 24 faded and HON settled around $214, I opened a bear put spread: bought the May 9 $215 put at $7.20, sold the May 9 $205 put at $2.60, net debit $4.60 per share.
The risk is straightforward. Maximum gain is $10 (the full spread width) if HON closes at or below $205 by May 9 — that's not my base case. I was positioned for a grind lower to $210–212, not a collapse. Maximum loss is the $4.60 debit if HON somehow reclaims $215 and holds there.
My thesis was simple: HON would drift lower in the days following the miss as sell-side analysts revised and the "wait for a better entry" consensus formed. I wasn't predicting catastrophe. I was predicting mean reversion on a disappointed premium multiple.
By April 25, with HON at $212.20, the spread was marked at $5.20. That's $600 of unrealized gain on $4,600 of risk capital — 13% on the debit, or approximately 6.5% of my total thesis allocation when I include the cash reserved against the position.
The spread remains open. Target exit is $5.80–6.00 if HON continues drifting lower. I'll close before May 9 regardless of outcome.
A Note on Separating Views
I want to be explicit: I did not fade HON because I have a negative view of the business. The aerospace spin-off narrative — Honeywell Aerospace going public on June 29 — is a legitimate value unlock, and the underlying building technologies and safety division generates stable cash flow. I faded HON because the short-term post-earnings setup was unfavorable and the options premium was mispriced relative to my expected near-term path. Those are two different views, and keeping them separate is the only way to trade rationally around events.